Evidence map›Paper›PMID 41018449›Full record

ArticleCureus2025

Hyperkinetic Gallbladder Syndrome: A Retrospective Study.

Jose L Mejia, Luis A Mejia Sierra

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jose L MejiaSurgery, WellSpan Ephrata Community Hospital, Ephrata, USA.
Luis A Mejia SierraVascular Surgery, Northwell Health, Long Island, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gallbladder dysmotility issues present a significant challenge for clinicians and general surgeons. Adding a hepato-biliary scan to the diagnostic toolkit has greatly helped in understanding this condition, but how to proceed when dealing with hypermotility remains a real challenge, as predicting the outcome of a cholecystectomy, due to limited research, is difficult. Patients typically come to the office after an extended workup, with ultrasound and CT scans showing no abnormalities, normal liver chemistries, and an abnormal ejection fraction. At this point, the surgeon must clarify the plan and manage the patient's expectations. A retrospective review was conducted of all cases encountered by a single surgeon over a two-year period in patients who presented to the office with biliary-type symptoms, normal ultrasound results, and an elevated ejection fraction on hepatobiliary iminodiacetic acid (HIDA) scan. The problem was classified as Hyperkinetic Gallbladder Syndrome (HGS) and given a grade. The primary goal was to identify pathological abnormalities in the collected specimens and to relieve symptoms. Among all the laparoscopic cholecystectomies performed during this period, 32 cases with symptoms, negative ultrasounds, and elevated ejection fractions were identified. The male-to-female ratio was 1:4 (81% female patients), the median age range was 41-50 years, and 23 out of 32 patients had an ejection fraction above 80%. All removed specimens showed chronic cholecystitis in the histopathologic examination, and 30 out of 32 patients experienced symptom resolution at two to three weeks of follow-up. HGS is a legitimate condition, and when patients are properly evaluated and other causes for their symptoms are carefully ruled out, laparoscopic cholecystectomy can alleviate the symptoms. It is crucial to select patients appropriately and set clear expectations.

Indexed as

acalculous gallbladderchronic cholecystitiselevated hida scan resultgallbladder dysmotilityhyperkinetic gallbladder

Identifiers

PMID41018449
PMCPMC12474524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.